Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01016327 · ClinicalTrials.gov registry record · Phase 1
Study of NMS-1116354 in Solid Tumors
A Phase 1 study, sponsored by Nerviano Medical Sciences.
- Terminated
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01016327 is a Phase 1 study that was terminated before completion, run by Nerviano Medical Sciences. The registered enrollment target is 15 participants.
The verdict
NCT01016327, a Phase 1 study, was terminated before completion, sponsored by Nerviano Medical Sciences.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety profile of NMS-1116354, a CDC7 kinase inhibitor, in adult patients with advanced solid tumors.
Interventions
- DRUG NMS-1116354
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01016327
The ClinicalTrials.gov registry entry for NCT01016327 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nerviano Medical Sciences, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NMS-1116354 is the first listed.
NCT01016327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01016327 about?
NCT01016327 is a clinical study titled "Study of NMS-1116354 in Solid Tumors". The purpose of this study is to evaluate the safety profile of NMS-1116354, a CDC7 kinase inhibitor, in adult patients with advanced solid tumors.
What is the current status of trial NCT01016327?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2009-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01016327?
The interventions under investigation include: NMS-1116354 (DRUG).
Who is sponsoring clinical trial NCT01016327?
This trial is sponsored by Nerviano Medical Sciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.